Today's Daily Dose brings you news about what's in store for Antares' XYOSTED; BioDelivery Sciences' Settlement Agreement with Teva; reverse stock split of CHF Solutions; FDA approval of Pfizer's LYRICA CR; and FDA panel recommendation for approval of Spark's gene therapy for blindness.
from RTT - Biotech http://ift.tt/2gBTLl2
via IFTTT
No comments:
Post a Comment